Next Article in Journal

Baseline Splenic Volume Outweighs Immuno-Modulated Size Changes with Regard to Survival Outcome in Patients with Hepatocellular Carcinoma under Immunotherapy

Next Article in Special Issue

Using Patient-Derived Xenograft (PDX) Models as a ‘Black Box’ to Identify More Applicable Patients for ADP-Ribose Polymerase Inhibitor (PARPi) Treatment in Ovarian Cancer: Searching for Novel Molecular and Clinical Biomarkers and Performing a Prospective Preclinical Trial

Previous Article in Journal

Early Prediction of Planning Adaptation Requirement Indication Due to Volumetric Alterations in Head and Neck Cancer Radiotherapy: A Machine Learning Approach

Previous Article in Special Issue

PARP Inhibitors Resistance: Mechanisms and Perspectives

You seem to have javascript disabled. Please note that many of the page functionalities won't work as expected without javascript enabled.

Search for Articles:

Title / Keyword

Author / Affiliation / Email

Journal

Article Type

Advanced Search

Section

Special Issue

Volume

Issue

Number

Page

Logical OperatorOperator

Search Text

Search Type

Submit to this Journal Review for this Journal Propose a Special Issue

Article Menu

Share Help Cite Discuss in SciProfiles

Open AccessArticle

Article Versions Notes

Cancers 2022, 14(15), 3572; https://doi.org/10.3390/cancers14153572

Action	Date	Notes	Link
article xml file uploaded	22 July 2022 13:08 CEST	Original file	-
article xml uploaded.	22 July 2022 13:08 CEST	Update	https://www.mdpi.com/2072-6694/14/15/3572/xml
article pdf uploaded.	22 July 2022 13:08 CEST	Version of Record	https://www.mdpi.com/2072-6694/14/15/3572/pdf
article supplementary file uploaded.	22 July 2022 13:08 CEST	-	https://www.mdpi.com/2072-6694/14/15/3572#supplementary
article html file updated	22 July 2022 13:09 CEST	Original file	-
article html file updated	13 August 2022 03:09 CEST	Update	https://www.mdpi.com/2072-6694/14/15/3572/html

Back to TopTop